Genomics
> New York City's Hospital for Special Surgery has received a $5.6 million grant from The Tow Foundation to establish the Hospital for Special Surgery Genomics Center, which will study rheumatoid arthritis and systemic lupus erythematosus with the goal of developing more personalized therapies. Release
> Houston-based genomics and genetics testing company Gene By Gene announced that it has signed an agreement with the University of Texas MD Anderson Cancer Center to become one of its affiliated clinical laboratories. Release
Autoimmune Disorders
> arGEN-X has advanced its antibody ARGX-113 into preclinical development for autoimmune disorders. Release
Muscular Dystrophy
> Nicox S.A. presented promising new data at the Muscular Dystrophy Association Scientific Conference in Washington, D.C., for its naproxcinod, a CINOD (cyclooxygenase-inhibiting nitric oxide-donating) anti-inflammatory candidate in models of muscular dystrophies. Release
> Scientists at Stanford University have created a mouse model of muscular dystrophy in which a protein lights up degenerating muscle tissue, making it easier to study. News
Liver Disease
> At the International Liver Congress in Amsterdam, Galectin Therapeutics and the Icahn School of Medicine at Mount Sinai presented positive preclinical data for two drugs that reverse the most advanced stage of liver fibrosis, called cirrhosis, in experimental animals given toxin-induced cirrhosis. Release
And Finally… The Blavatnik Family Foundation has donated $50 million to Harvard University to transform early-stage research into new breakthrough therapies for patients and cures for disease. Item